Company news
Canntab Therapeutics Limited news in 2021
Canntab Therapeutics Limited's news releases, calls and decks from 2021, newest first.
Canntab enters into strategic partnership to provide alternatives to opiates through levitee clinics
December 16, 2021
Canntab Receives Medical Sales Licence from Health Canada
November 11, 2021
Canntab Reaches Agreement with Innovative Bioinformatics Company, 36eight Technologies Inc.
October 18, 2021
Canntab Announces the Early Exercise of $1,259,250 Warrants
June 3, 2021
Canntab Mourns the Loss of Co-Founder
May 25, 2021
Canntab Receives Export License Approval from Health Canada
March 30, 2021
Canntab Granted 3rd Patent and Receives $400K Purchase Order in Australia
March 9, 2021
Canntab Fulfills 80% of Its Contract with MediPharm Labs Corp.
March 3, 2021
Canntab Engages Independent Trading Group for Market Making Services
February 17, 2021
Canntab Grants Options
February 3, 2021
Canntab Granted 2nd Patent For Immediate Release Cannabidiol Formulation Tablets
February 1, 2021
Decks in 2021
- Investor Presentation (September 2021)
Investor deck · 15 slides · September 2021
- Investor Presentation (May 2021)
Investor deck · 15 slides · May 2021